Specialties:

Most Popular Reports:

Newest Reports:

ICD/CRT-D Lead Market Assessment

A Survey of Fifty-One Electrophysiologists

February 2008

Price $2500

Deliverable:  Survey with Key Findings.

Study Description:

Topic

ICD/CRT-D Lead Market Assessment

Respondent Type

Physicians

Specialties Covered

Electrophysiologists

Region

United States Only

Methodology

Online survey, self-administered via a Panel Intelligence website

Duration: 20 minutes

Size: 51 respondents

Fielding Dates: February 14th to February 25th 2008

Objectives:

To understand electrophysiologists� perceptions and usage of ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device & defibrillation) leads.

    Assess the current market and estimate the growth in the number of ICD/CRT-D procedures over the next two years.

    Determine the current and future use of ICD/CRT-D leads from various manufacturers.

    Gauge the impact of Medtronic Sprint Fidelis recall in general and on 7 French ICD leads, specifically.

    Evaluate electrophysiologists� perceptions of product differentiation among ICDs with remote monitoring.

    Determine the current and future use of ICDs with remote monitoring from various manufacturers.

Companies mentioned in this report:

Company

Ticker Symbol

Medtronic

MDT

St. Jude Medical

STJ

Boston Scientific Corp.

BSX

Biotronik

[Private] Limited coverage

Sorin

SRN Limited coverage

Inclusion Criteria and Respondent Demographics

Inclusion Criteria

    US-based Electrophysiologists

    Board-certified/board eligible in specialty

    2 to 30 years of experience post-training

    Minimum of 75% professional time spent in clinical practice

    Perform at least 10 ICD/CRT-D implants per month

To purchase this report or request additional information, contact: 

 

Purchase this report Reports become free one year after the publication date.

 

> about us      > contact us
© Panel Intelligence, LLC. 1999-2008. All rights reserved.
A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR)
Privacy Policy